OBJECTIVE: Given the importance of fatigue in cancer, stroke and HIV, we sought to assess the measurement properties of a single, well-described fatigue scale in these populations. We hypothesized that the psychometric properties of the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) subscale would be favorable and that the scale could serve as a useful indicator of fatigue in these populations. METHODS: Patients were eligible for the study if they were outpatients, aged 18 or older, with a diagnosis of cancer (n=297), stroke (n=51), or HIV/AIDS (n=51). All participants were able to understand and speak English. Patients answered study-related questions, including the FACIT-F using a touch-screen laptop, assisted by the research assistant as necessary. Clinical information was abstracted from patients' medical records. RESULTS: Item-level statistics on the FACIT-F were similar across the groups and internal consistency reliability was uniformly high (α>0.91). Correlations with performance status ratings were statistically significant across the groups (range r=-0.28 to -0.80). Fatigue scores were moderately to highly correlated with general quality of life (range r=0.66-0.80) in patients with cancer, stroke, and HIV. Divergent validity was supported in low correlations with variables not expected to correlate with fatigue. CONCLUSIONS: Originally developed to assess cancer-related fatigue, the FACIT-F has utility as a measure of fatigue in other populations, such as stroke and HIV. Ongoing research will soon allow for comparison of FACIT-F scores to those obtained using the fatigue measures from the Patient-Reported Outcomes Measurement Information System (PROMIS®; www.nihpromis.org) initiative.
OBJECTIVE: Given the importance of fatigue in cancer, stroke and HIV, we sought to assess the measurement properties of a single, well-described fatigue scale in these populations. We hypothesized that the psychometric properties of the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) subscale would be favorable and that the scale could serve as a useful indicator of fatigue in these populations. METHODS:Patients were eligible for the study if they were outpatients, aged 18 or older, with a diagnosis of cancer (n=297), stroke (n=51), or HIV/AIDS (n=51). All participants were able to understand and speak English. Patients answered study-related questions, including the FACIT-F using a touch-screen laptop, assisted by the research assistant as necessary. Clinical information was abstracted from patients' medical records. RESULTS: Item-level statistics on the FACIT-F were similar across the groups and internal consistency reliability was uniformly high (α>0.91). Correlations with performance status ratings were statistically significant across the groups (range r=-0.28 to -0.80). Fatigue scores were moderately to highly correlated with general quality of life (range r=0.66-0.80) in patients with cancer, stroke, and HIV. Divergent validity was supported in low correlations with variables not expected to correlate with fatigue. CONCLUSIONS: Originally developed to assess cancer-related fatigue, the FACIT-F has utility as a measure of fatigue in other populations, such as stroke and HIV. Ongoing research will soon allow for comparison of FACIT-F scores to those obtained using the fatigue measures from the Patient-Reported Outcomes Measurement Information System (PROMIS®; www.nihpromis.org) initiative.
Authors: Jin-Shei Lai; David Cella; Kelly Dineen; Rita Bode; Jamie Von Roenn; Richard C Gershon; Daniel Shevrin Journal: J Clin Epidemiol Date: 2005-02 Impact factor: 6.437
Authors: Thomas M Atkinson; Charissa F Andreotti; Kailey E Roberts; Rebecca M Saracino; Marisol Hernandez; Ethan Basch Journal: Support Care Cancer Date: 2015-08-28 Impact factor: 3.603
Authors: Jasmine Yee; Glen M Davis; Jane M Beith; Nicholas Wilcken; David Currow; Jon Emery; Jane Phillips; Andrew Martin; Rina Hui; Michelle Harrison; Eva Segelov; Sharon L Kilbreath Journal: J Cancer Surviv Date: 2014-07-02 Impact factor: 4.442
Authors: Thanh Tran; Viola Guardigni; Karol M Pencina; Anthony A Amato; Michael Floyd; Brooke Brawley; Brian Mozeleski; Jennifer McKinnon; Erin Woodbury; Emily Heckel; Zhuoying Li; Tom Storer; Paul E Sax; Monty Montano Journal: Clin Infect Dis Date: 2018-06-01 Impact factor: 9.079
Authors: Ryne Estabrook; David Cella; Fengmin Zhao; Judith Manola; Robert S DiPaola; Lynne I Wagner; Naomi B Haas Journal: Qual Life Res Date: 2018-03-05 Impact factor: 4.147
Authors: Mary Amanda Dew; Zeeshan Butt; Qian Liu; Mary Ann Simpson; Jarcy Zee; Daniela P Ladner; Susan Holtzman; Abigail R Smith; Elizabeth A Pomfret; Robert M Merion; Brenda W Gillespie; Averell H Sherker; Robert A Fisher; Kim M Olthoff; James R Burton; Norah A Terrault; Alyson N Fox; Andrea F DiMartini Journal: Transplantation Date: 2018-01 Impact factor: 4.939